Last update 07 Feb 2025

Recombinant 15-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms-
Target-
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsInfectious DiseasesSkin and Musculoskeletal Diseases+ [1]
Active Indication
Carcinoma in SituCondylomata AcuminataHPV-related carcinoma
Inactive Indication-
Originator Organization
Chongqing Bovax Biopharmaceutical Co., Ltd.Chongqing Bovax Biopharmaceutical Co., Ltd.Shanghai BOWEI BIOMEDICAL CO., LTDShanghai BOWEI BIOMEDICAL CO., LTD
Active Organization
Shanghai BOWEI BIOMEDICAL CO., LTDShanghai BOWEI BIOMEDICAL CO., LTD
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with Recombinant 15-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)
CTR20244986
/ RecruitingPhase 2
随机、双盲、阳性和安慰剂对照评估十五价重组人乳头瘤病毒疫苗（汉逊酵母）在9-45周岁中国健康人群中的安全性和免疫原性的Ⅱ期临床试验
[Translation] A randomized, double-blind, active and placebo-controlled phase II clinical trial to evaluate the safety and immunogenicity of the 15-valent recombinant human papillomavirus vaccine (Hansen yeast) in healthy Chinese people aged 9-45 years
NCT06756269
/ Active, not recruitingPhase 2
A Randomised, Double-blind, Placebo and Positive Controlled, Phase 2 Clinical Trial to Evaluate the Safety and Immunogenicity of 15-valent Human Papillomavirus Recombinant Vaccine (Hansenulapolymorpha) in Healthy Chinese People Aged 9-45 Years
CTR20242006
/ Active, not recruitingPhase 1
随机、双盲、安慰剂对照评估十五价重组人乳头瘤病毒疫苗（汉逊酵母）在9-45周岁中国健康人群中的安全性和耐受性的Ⅰ期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase I clinical trial to evaluate the safety and tolerability of the 15-valent recombinant human papillomavirus vaccine (Hansen yeast) in healthy Chinese people aged 9-45 years
100 Clinical Results associated with Recombinant 15-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)
Login to view more data
100 Translational Medicine associated with Recombinant 15-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)
Login to view more data
100 Patents (Medical) associated with Recombinant 15-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)
Login to view more data
100 Deals associated with Recombinant 15-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Carcinoma in SituPhase 2
CN
Shanghai BOWEI BIOMEDICAL CO., LTDShanghai BOWEI BIOMEDICAL CO., LTD
15 Jan 2025
Condylomata AcuminataPhase 2
CN
Shanghai BOWEI BIOMEDICAL CO., LTDShanghai BOWEI BIOMEDICAL CO., LTD
15 Jan 2025
HPV-related carcinomaPhase 2
CN
Shanghai BOWEI BIOMEDICAL CO., LTDShanghai BOWEI BIOMEDICAL CO., LTD
15 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free